The effects of dopaminergic agents on reaction time in rhesus monkeys

Psychopharmacology

Volumn 137, Issue 1, 1998, Pages 33-42

  Weed, Michael R ^a   Gold, Lisa H ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Amphetamine SCH 39166; Movement; Raclopride; Reaction time; Rhesus monkey

Indexed keywords

AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; RACLOPRIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; ASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUNTINGTON CHOREA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REACTION TIME; RHESUS MONKEY;

ANIMALS; BENZAZEPINES; DEXTROAMPHETAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA MULATTA; MALE; MOTOR ACTIVITY; RACLOPRIDE; REACTION TIME; SALICYLAMIDES;

EID: 0031977841     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050590     Document Type: Article

References (33)

1. 2 dopamine receptor antagonism in a reaction-time task in rats. Neuropsychologia 31: 459-469
2. Amalric M, Moukhles H, Nieoullon A, Daszuta A (1995) Complex deficits on reaction time performance following bilateral intrastrialal 6-OHDA infusion in the rat. Behav Neurosci 109: 227-240
3. Baunez C, Nieoullon A, Amalric M (1995) Dopamine and complex sensorimotor integration: further studies in a conditioned motor task in the rat. FEBS Lett 366: 165-169
4. 2 dopamine receptor antagonists in squirrel monkeys. J Pharmacol Exp Ther 258: 910-917
5. Blanchet P, Bedard PJ, Brilton DR, Kebabian JW (1993) Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-metliyl-4-plienyl-1,2,3,6-tetrahydropyridine-exposed monkeys. J Pharmacol Exp Ther 267: 275-279
6. Brown VJ, Rohbins TW (1991) Simple and choice reaction time performance following unilateral striatal dopamine depletion in the rat: Impaired motor readiness but preserved response preparation. Brain Res 543: 335-340
7. 1 selective benzonaphthazepine with potential antipsychotic activity. J Pharmacol Exp Ther 247: 1093-1102
8. Conde H, Benita M, Dormont JF, Schmied A, Cadoret A (1981) Control of reaction time performance involves the striatum. J Physiol Paris 77: 97-105
9. Dunlop O, Bjorklund RA, Abdelnoor M, Myrvang B (1992) Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 86: 260-266
10. Ellis JE, Byrd LD, Bakay RA (1992) A method for quantitating motor deficits in a nonhuman primate following MPTP-induced hemiparkinsonism and co-grafting. Exp Neurol 115: 376-387
11. Evarts EV, Teravainen H, Calne DB (1981) Reaction time in Parkinson's disease. Brain 104: 167-186
12. 2-dopamine receptor antagonist raclopride - pharmacokinetics, safety and tolerability in healthy males, Int Clin Psychopharmacol 4: 115-126
13. Geisser S, Greenhouse SW (1958) An extension of Box's results on the use of the F distribution in multivariate analysis. Ann Math Statist 29: 885-891
14. 11C-labeled dopamine receptor antagonists in the brain of rhesus monkeys studied with positron emission tomography. Acta Neurol Scand 77: 314-321
15. Hienz RD, Lukas SE, Brady JV (1985) Effects of d-methamphetamine on auditory and visual reaction times and detection thresholds in the baboon. Psychopharmacology 85: 476-482
16. Hienz RD, Spear DJ, Brady JV, Bowers DA (1993) Effects of cocaine on sensory motor function in baboons. Pharmacol Biochem Behav 45: 399-408
17. Hienz, RD, Spear DJ, Bowers DA (1994) Effects of cocaine on simple reaction times and sensory thresholds in baboons. J Exp Anal Behav 61: 231-246
18. Juhanshani M, Brown RG, Marsden CD (1993) A comparative study of simple and choice reaction time in Parkinson's, Huntington's, and cerebellar disease. J Neurol Neurosurg Psychiatry 56: 1169-1177
19. 1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys. Pharmacol Biochem Behav 51: 617-622
20. Karlsen NR, Reinvang I, Froland SS (1992) Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 86: 242-246
21. 1 dopamine receptor binding and occupancy in man. Psychopharmacology 121: 300-308
22. Legallet E, Pons JC, Trouche E (1994) Methods of motor performance evaluation: application to a primate model for basal ganglia pathology. J Neurosci Meth 55: 79-87
23. Marrow L, Overton P, Clark D (1993) Disruption of conditioned reaction time performance by dopamine receptor antagonists in the rat. Behav Pharmacol 4: 15-28
24. Martin E, Martin A, Heyes MP, Salazar AM, Kampen MS, Williams J, Law WA, Coats ME, Markey SP (1992) Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatr Clin Neurosci 4: 270-279
25. Mayfield RD, Randall PK, Spirduso WW, Wilcox RE (1993a) Apomorphine and amphetamine produce differential effects on the speed and success of reaction lime responding in the rat. Pharmacol Biochem Behav 46: 769-775
26. 2 dopamine receptor antagonists produce differential effects on reaction time in the rat. Pharmacol Biochem Behav 46: 759-768
27. Sahakian BJ, Owen AM, Morant NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R (1993) Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395-401
28. Sardar AM, Czudek C, Reynolds GP (1996) Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910-912
29. Schneider JS, Lidsky TI, Hawks T, Mazziotta JC, Hoffman JM (1995) Differential recovery of volitional motor function, lateralized cognitive function, dopamine agonist-induced rotation and dopaminergic parameters in monkeys made hemi-parkinsonian by intracarotid MPTP infusion. J Neurol Sci 129: 9-14
30. Siemers E, Foroud T, Bill D, Sorbel J, Norton J, Hodes M, Niebler G, Conneally P, Christian J (1996) Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 53: 487-492
31. Solomon RE, Herling S, Domino EF, Woods JH (1982) Discriminative stimulus effects of N-substituted analogs of phencyclidine in rhesus monkeys. Neuropharmacology 21: 1329-1336
32. 3H]SCH39166. Neurochem Int 20 [Suppl]: 123S-128S
33. Wenger GR (1980) Cumulative dose-response curves in behavioral pharmacology. Pharmacol Biochem Behav 13: 647-651